secwatch.observer — SEC 8-K summary
======================================

Issuer:     PHIBRO ANIMAL HEALTH CORP (PAHC)
CIK:        0001069899
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0001558370-25-006760
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phibro Animal Health Q3 net sales up 32% to $347.8M; Adj EBITDA +85%; raises FY2025 guidance
--------------------------------------------------------------------------------

- Q3 net sales $347.8M (+32% YoY); net income $20.9M (+$12.5M); diluted EPS $0.51 (+$0.30).
- Adjusted EBITDA $54.9M (+85% YoY); adjusted diluted EPS $0.63 (+$0.32).
- Animal Health segment sales +42% driven by Zoetis MFA acquisition; legacy Animal Health flat.
- Updated FY2025 guidance: net sales $1.26B-$1.29B, Adj EBITDA $177M-$183M (62% growth at midpoint).
- Gross leverage ratio 3.0x; free cash flow $49.1M for trailing twelve months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069899/000155837025006760/0001558370-25-006760-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069899/000155837025006760/pahc-20250507x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-006760

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer